One-Third of Older Americans Have Received a Shingles Vaccine
Shingles vaccination rates have risen from 6.7% in 2008 to 34.5% in 2018 among American adults 60 and older.
Clinics Have Capacity to Help Families Catch Up on Vaccinations During COVID
Many families fell behind on vaccines during the pandemic, but a study finds most clinics are available to schedule make-up appointments.
Ebola Outbreak Reaches 60 Patients in Mbandaka, DRC
How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?
FDA Approves OraRisk Coronavirus PCR Test
The test is not FDA approved, but is instead authorized for emergency use in the context of the SARS-CoV-2 pandemic.
Probiotic Use Among Older Care Home Residents Does Not Reduce Antibiotic Use
A common combination of probiotics showed no benefits for reducing antibiotic administration in older adults in care homes, according to a study led by Oxford University investigators.
Calling Upon Florida and the Nation to Require Face Masks
A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.
Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Isolation Precautions and COVID-19: How Long is Enough?
Should we be reconsidering the length of time patients are isolated?
Loss of Life From Antibiotic Resistance May Surpass Cancer By 2050
Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.
COVID-19 Investigational Therapy Approved for Phase 2 Study
The FDA clears way for next phase for abivertinib to treat hospitalized patients.
Adenovirus Vector Vaccine Shows Promise Against SARS-CoV-2
A single injection of the Ad5-vectored COVID-19 vaccine induced specific immune responses to the spike glycoprotein at day 28.
Mortality Rates in Hospitalized COVID-19 Patients on Dexamethasone Lower VS Usual Care
This was seen in patients who were receiving either invasive mechanical ventilation or oxygen.
UK Orders Large Quantity of Pfizer mRNA Vaccine
The development of BNT162 is based on BioNTech’s mRNA platform; the vaccine will then be produced using Pfizer’s vaccine manufacturing capacities.
University of Oxford COVID-19 Vaccine Induces Strong Immune Responses
New data shows the ChAdOx1 nCoV-19 vaccine candidate induces T cell response within 14 days, and antibody response within 28 days.
COVID-19 Antibody Test Receives EUA
Luminex Receives FDA Emergency Use Authorization for its xMAP SARS-CoV-2 Multi-Antigen IgG Assay.
FDA Grants Emergency Authorization for COVID-19 Specimen Pooling
Quest Diagnostics will now able to efficiently test larger groups of specimen among persons from low-coronavirus risk areas.
CDC Survey Reveals Telling Information on COVID-19 Outpatients
Results highlight burden of disease and potential issues associated with contact tracing.
Catching the Flu Increases Risk for Invasive Pneumococcal Disease
Contracting influenza increased the risk for invasive pneumococcal disease in a study conducted across 3 countries.
A Timeline to Heparin in COVID-19 Patients
Perspective on how the anticoagulant could progress to human trials and potentially, marketing use for coronavirus prevention.
Symptoms Remain After COVID-19 Treatment
In a small Italian study, a majority of patients who were hospitalized and recovered from the virus, had lingering symptoms and many had a “worsened quality of life.”
FDA Issues More Sanitizer Recalls Over Methanol Content
Weekly, we identify FDA announcements that pertain to infectious disease care. This week, FDA continued an investigation of undeclared wood alcohol contents in hand sanitizer.
Serial Testing Identifies COVID-19 Cases at a Corrections Facility
Asymptomatic and presymptomatic cases of COVID-19 create challenges for identifying and combating the spread of the virus in detention facilities.
Could Heparin Prevent Coronavirus Infection?
A discussion with an RPI investigator after promising early findings.
COVID-19 Pandemic Threatens Global Infectious Disease Control Progress
A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
Improving Influenza Surveillance Systems to Help the Most Vulnerable At-Risk Patients
A model including clinical symptom reports, Internet searches, and emergency room data predict influenza hospitalizations better in affluent vs. poorer communities.
Applying African Ebola Response Experience to the Coronavirus Pandemic
West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.
The Dangers of Respiratory Droplets to Frontline Health Care Providers
A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.
How Will Coronavirus Impact HIV, TB, & Malaria in Developing African Countries?
A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.
Understanding Excess Deaths in the Wake of COVID-19
The burden of COVID-19 is far reaching and a new study into excess mortality sheds light on this saddening topic.
Hydroxychloroquine, Chloroquine Prescriptions Spiked as COVID-19 Reached US
Tens of thousands of patients were prescribed the anti-malarial drugs in the early weeks of the pandemic, a statistic that concerns public health officials.
